Bacteria-based cancer therapy: Looking forward
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tieu, My-Van | - |
dc.contributor.author | Pham, Duc-Trung | - |
dc.contributor.author | Cho, Sungbo | - |
dc.date.accessioned | 2024-07-06T11:30:45Z | - |
dc.date.available | 2024-07-06T11:30:45Z | - |
dc.date.issued | 2024-07 | - |
dc.identifier.issn | 0304-419X | - |
dc.identifier.issn | 1879-2561 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/91746 | - |
dc.description.abstract | The field of bacteria-based cancer therapy, which focuses on the key role played by the prevalence of bacteria, specifically in tumors, in controlling potential targets for cancer therapy, has grown enormously over the past few decades. In this review, we discuss, for the first time, the global cancer situation and the timeline for using bacteria in cancer therapy. We also explore how interdisciplinary collaboration has contributed to the evolution of bacteria-based cancer therapies. Additionally, we address the challenges that need to be overcome for bacteria-based cancer therapy to be accepted in clinical trials and the latest advancements in the field. The groundbreaking technologies developed through bacteria-based cancer therapy have opened up new therapeutic strategies for a wide range of therapeutics in cancer. © 2023 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Elsevier | - |
dc.title | Bacteria-based cancer therapy: Looking forward | - |
dc.type | Article | - |
dc.identifier.wosid | 001244005000001 | - |
dc.identifier.doi | 10.1016/j.bbcan.2024.189112 | - |
dc.identifier.bibliographicCitation | Biochimica et Biophysica Acta - Reviews on Cancer, v.1879, no.4 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85193432628 | - |
dc.citation.title | Biochimica et Biophysica Acta - Reviews on Cancer | - |
dc.citation.volume | 1879 | - |
dc.citation.number | 4 | - |
dc.type.docType | Review | - |
dc.publisher.location | 네델란드 | - |
dc.subject.keywordAuthor | Bacteria cancer therapy | - |
dc.subject.keywordAuthor | Biological engineering | - |
dc.subject.keywordAuthor | Engineered bacteria | - |
dc.subject.keywordAuthor | Wild-typed bacteria | - |
dc.subject.keywordPlus | SALMONELLA-TYPHIMURIUM | - |
dc.subject.keywordPlus | LACTOBACILLUS-PLANTARUM | - |
dc.subject.keywordPlus | TARGETING BACTERIA | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordPlus | STRATEGY | - |
dc.subject.keywordPlus | CASEI | - |
dc.subject.keywordPlus | RISK | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.